Skip to content
New users? Get 5% off on your first purchase.
Free US shipping over $100
New users? Get 5% off on your first purchase.
Free US shipping over $100

Added to your cart:

Cart subtotal

Ogivri Trastuzumab-Dkst Injection 150 mg **Refrigeration Required** (RX)

SKU 83257-0001-11
Sale 47%
Original price $ 2,450.00
Current price $ 1,295.00
*Mountainside Medical does not fill personal prescriptions Medical Professional License Required to Unlock Account

How to Order:

Send an email request to: sales@mountainside-medical.com

You will receive instructions on how to create an account along with Rx Ordering Details.

(Note: Acceptable licenses must have Prescriptive Authority in the license issuing state.)
Fast Delivery
Fast Delivery
24/7 Support
24/7 Support
Easy Returns
Easy Returns
Hospital Grade
Hospital Grade
Save 47% ($ 1,155.00)
Free Shipping on orders above $100
Returns 30-day return / replacement
Payment Secure transaction
Packaging Ships in product packaging
Service-Disabled Veteran-Owned Small Business
Service-Disabled Veteran-Owned Small Business
Located in Adirondack Mountains in NY
Located in Adirondack Mountains in NY
Family Owned Business 2002
Family Owned Business 2002
Sale 47%
Original price $ 2,450.00
Current price $ 1,295.00
Free Shipping on orders above $100
Returns 30-day return / replacement
Payment Secure transaction
Packaging Ships in product packaging
Ogivri Trastuzumab-Dkst Injection 150 mg **Refrigeration Required** (RX)
Ogivri Trastuzumab-Dkst Injection 150 mg **Refrigeration Required** (RX)
$ 2,450.00 $ 1,295.00
🔒 Medical License Required
Description

Ogivri Trastuzumab-Dkst Injection 150 mg is a medication used in the treatment of certain types of breast cancer and stomach cancer. It contains the active ingredient trastuzumab and belongs to a class of drugs known as monoclonal antibodies. It works by specifically targeting and blocking the action of a protein called HER2, which is overexpressed in some types of cancer cells. By blocking HER2, Ogivri helps to slow down or stop the growth and spread of cancer cells.

Ogivri Trastuzumab-Dkst Injection 150 mg is a type of cancer medication called a monoclonal antibody. It targets a protein called human epidermal growth factor receptor 2 (HER2) which is found on the surface of some cancer cells. By binding to HER2, Ogivri helps to slow down or stop the growth and spread of HER2-positive cancer cells.

Specifically, Ogivri works by blocking the action of HER2, which is involved in stimulating cell growth and division. This helps to slow down the growth of cancer cells and can potentially lead to their death. In addition, Ogivri also stimulates an immune response against the cancer cells, further aiding in their destruction.

Overall, by targeting HER2 and stimulating the immune system, Ogivri can help to treat certain types of breast and stomach cancers that overexpress this protein.

Get Notified When Back in Stock